Clinical and Neurological Features of Complications in Patients After Covid-19

Main Article Content

Nilufar Rashidova
Saykha Ilkhomova

Abstract

COVID-19 infection, which was known to all and attracted the attention of medical professionals due to its effects on the body, is considered one of the current problems, and in addition to the new clinical sign of the disease, its impact on the course of chronic diseases also manifests itself in different ways. With the end of the pandemic, the manifestation of complications in this disease is a new medical condition that requires new research and observation.

Article Details

How to Cite
Nilufar Rashidova, & Saykha Ilkhomova. (2023). Clinical and Neurological Features of Complications in Patients After Covid-19. Journal of Coastal Life Medicine, 11(2), 1277–1280. Retrieved from https://www.jclmm.com/index.php/journal/article/view/1154
Section
Articles

References

V.V. Belopasov, Ya. Yasha, E.M. Samoilova, V.P., Baklaushev. // Damage to the nervous system in Сovid-19//https://cyberleninka.ru/article/n/porazhenie-nervnoy-sistemy-pri-Covid-19

Gusev E.I., Martynov M.Yu., Boyko A.N., Voznbk I.A., Lashch N.Yu., Sivertseva S.A., Spirin N.N., Shamalov N.A. New coronavirus infection (Covid-19) and damage to the nervous system: mechanisms of neurological disorders, clinical manifestations, organization of neurological care // Journal of Neurology and Psychiatry named after S.S. Korsakov, 2020; 120(6): 7-16 b.

Usanova A.A., Kunyaeva T.A., Usanova T.A., Ratin K.Yu. Neurological risks of a new coronavirus infection Covid-19 // Journal of Modern Problems and Education, 2022, No. 6 part 2 P.25

Matmurodov R.J., Umirova S.M. The role of coronavirus infection in the development of diabetic polyneuropathy and its effect on the complement system // Tashkent-2021, Journal of Biomedicine and Practice, volume 6, issue 3, page 256.

Matmurodov R.J., Umirova S.M. Rezulty primeneniya kombilepena v lechenii diabeticeskoy polyneuropatii u lits molodogo vozrasta // Journal of cardiorespiratory research. No. SI-1 (2021), p. 187

R.G. Esin, O.R. Esin, E.A. Gorobets, I.M. Fattakhov. //Neurological complications of the new coronavirus infection Сovid-19// Educational and methodological manual for neurologists and clinical psychologists UDC 616.8; LBC 56.12; H12 Kazan 2021.

Elgamasy S, Kamel MG, Ghozy S, et al. The first case of focal epilepsy is associated with sars-coronavirus-2. J Med Virol. 2020;10.1002/jmv.26113. doi: 10.1002/ jmv.26113

Fasano A, Cavalieri F, Canali E, Valzania F. First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci. 2020:1-3. doi: 10.1007/ s10072-020-04460.

Guillan M, Villacieros-Alvarez J, Bellido S, Perez-Jorge Peremarch C. et al. Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient. J.Thromb Res. 2020 Jun 9;193:107-109. doi 10.1016/j. Thomas.2020.06.015

Hepburn M, Mullaguri N, George P, et al. Acute symptomatic seizures in critically Ill patients with COVID-19: Is there an association? Neurocrit Care. 2020;1–5. doi 10.1007/s12028-020-01006-1.

Kuroda N. Epilepsy and COVID-19: Associations and important considerations. Epilepsy Behav. 2020;108:107122. doi: 10.1016/j.yebeh.2020.107122.

Li Y, Wang M, Zhou Y, et al. Acute cerebrovascular disease following COVID-19: a single, retrospective, observational study. Lancet. 2020. doi 10.2139/ ssrn.3550025.

Lu L, Xiong W, Liu D, Liu J. et al. New-onset acute symptomatic seizure and risk in Coronavirus Diseases 2019: A retrospective multicenter study. Epilepsia. 2020;61(6):e49–e53. doi 10.1111/ epi.16524.

Lai C-C, Liu YH, Wang C-Yi, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020;53(3):404–412. doi 10.1016/j.jmii.2020.02.012

Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., Miao X., Li Y., Hu B. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA neurology. 2020; 77(6): 683–690. https://doi.org/10.1001/jamaneurol.2020.1127

Nordvig A.S., Fong K.T., Willey J.Z., Thakur K.T., Boehme A.K., Vargas W.S., Smith C.J., Elkind M. Potential Neurologic Manifestations of COVID-19. Neurology. Clinical practice. 2021; 11(2): e135–e146. https://doi. org/10.1212/CPJ.0000000000000897

Tu W.J, Cao J, Yu L, et al. Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan. Intensive Care Med. 2020;46(6):1117–1120. doi 10.1007/ s00134-020-06023-4.

Zubair A.S, McAlpine LS, Gardin T, et al. Neuropathogenesis and neurologic manifestations of the Coronaviruses in the age of Coronavirus disease 2019: A review. JAMA Neurol. 2020. doi: 10.1001/jamaneurol.2020.2065